Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Thrombocytosis D013922 4 associated lipids
Toxemia D014115 3 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Klebsiella Infections D007710 7 associated lipids
Ascites D001201 25 associated lipids
Albuminuria D000419 18 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Parkinson Disease D010300 53 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Bronchial Diseases D001982 3 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Tangier Disease D013631 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Leslie CC and Detty DM Arachidonic acid turnover in response to lipopolysaccharide and opsonized zymosan in human monocyte-derived macrophages. 1986 Biochem. J. pmid:3098232
Joseph S and MacDermot J Thrombin promotes actin polymerization in U937 human monocyte-macrophage cells. Analysis of the signalling mechanisms mediating actin polymerization. 1992 Biochem. J. pmid:1417754
Hallam TJ et al. Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2. 1984 Biochem. J. pmid:6426464
Baldi E et al. Stimulation of platelet-activating factor synthesis by progesterone and A23187 in human spermatozoa. 1993 Biochem. J. pmid:8503848
Salari H et al. Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets. 1990 Biochem. J. pmid:2160234
Seifert R et al. Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides. 1990 Biochem. J. pmid:2160237
MacIntyre DE and Pollock WK Platelet-activating factor stimulates phosphatidylinositol turnover in human platelets. 1983 Biochem. J. pmid:6411067
Wang H et al. Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. 1997 Biochem. J. pmid:9065783
Kloprogge E et al. PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy. 1986 Biochem. J. pmid:3800968
Triggiani M et al. Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. 1992 Biochem. J. pmid:1530582
Nahas N et al. Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. 1996 Biochem. J. pmid:8761479
Gómez-Cambronero J et al. The role of calcium ions in the process of acetyltransferase activation during the formation of platelet-activating factor (PAF-acether). 1984 Biochem. J. pmid:6146309
Tsoukatos DC et al. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. 2001 Biochem. J. pmid:11439095
Kloprogge E and Akkerman JW Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. 1984 Biochem. J. pmid:6150705
Chao W et al. Biosynthesis of platelet-activating factor by cultured rat Kupffer cells stimulated with calcium ionophore A23187. 1989 Biochem. J. pmid:2494988
Dohi T et al. Calcium-dependent biosynthesis of platelet-activating factor by submandibular gland cells. 1991 Biochem. J. pmid:1645529
Laneuville O et al. Hepoxilin A3 inhibits the rise in free intracellular calcium evoked by formyl-methionyl-leucyl-phenylalanine, platelet-activating factor and leukotriene B4. 1993 Biochem. J. pmid:8240236
Cluzel M et al. Dynamics of platelet-activating-factor release and uptake in a human neutrophil suspension. 1991 Biochem. J. pmid:1898338
Alonso MT et al. Agonist-induced Ca2+ influx into human platelets is secondary to the emptying of intracellular Ca2+ stores. 1991 Biochem. J. pmid:1764041
Murphy CT and Westwick J Role of type 1 and type 2A phosphatases in signal transduction of platelet-activating-factor-stimulated rabbit platelets. 1994 Biochem. J. pmid:8042999
DiCorleto PE and de la Motte CA Thrombin causes increased monocytic-cell adhesion to endothelial cells through a protein kinase C-dependent pathway. 1989 Biochem. J. pmid:2513808
O'Flaherty JT et al. Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils. 1992 Biochem. J. pmid:1332696
Chao W et al. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells. 1989 Biochem. J. pmid:2775221
Tool AT et al. Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils. 1999 Biochem. J. pmid:10229663
Dulioust A et al. Biosynthesis of paf-acether. Paf-acether but not leukotriene C4 production is impaired in cultured macrophages. 1989 Biochem. J. pmid:2513801
Rodrigo L et al. Hydrolysis of platelet-activating factor by human serum paraoxonase. 2001 Biochem. J. pmid:11171072
Winkler JD et al. Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil. 1993 Biochem. J. pmid:8387780
Rogers JE et al. Solubilization of a functionally active platelet-activating factor receptor from rabbit platelets. 1991 Biochem. J. pmid:1654881
Chao W et al. Protein tyrosine phosphorylation and regulation of the receptor for platelet-activating factor in rat Kupffer cells. Effect of sodium vanadate. 1992 Biochem. J. pmid:1335232
Hii CS et al. Basal and phorbol-ester-stimulated turnover of phosphatidylcholine in HeLa cells involve different pathways. 1992 Biochem. J. pmid:1335237
Snyder F Platelet-activating factor: the biosynthetic and catabolic enzymes. 1995 Biochem. J. pmid:7848265
Touqui L et al. Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked. 1985 Biochem. J. pmid:4052028
Alonso-Torre SR et al. Control of Ca2+ entry into HL60 and U937 human leukaemia cells by the filling state of the intracellular Ca2+ stores. 1993 Biochem. J. pmid:8382050
Houslay MD et al. Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni. 1986 Biochem. J. pmid:3013161
Halenda SP and Rehm AG Evidence for the calcium-dependent activation of phospholipase D in thrombin-stimulated human erythroleukaemia cells. 1990 Biochem. J. pmid:2159285
Kjeldsen L et al. Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules. 1992 Biochem. J. pmid:1332677
Grigg ME et al. Characterization of a platelet-activating factor acetylhydrolase secreted by the nematode parasite Nippostrongylus brasiliensis. 1996 Biochem. J. pmid:8713083
Yousufzai SY and Abdel-Latif AA Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists. 1985 Biochem. J. pmid:3927898
Tran K et al. Vitamin E enhances the acylation of 1-O-alkyl-sn-glycero-3-phosphocholine in human endothelial cells. 1994 Biochem. J. pmid:8129709
Montero M et al. Control of plasma-membrane Ca2+ entry by the intracellular Ca2+ stores. Kinetic evidence for a short-lived mediator. 1992 Biochem. J. pmid:1463455
Bauldry SA and Wooten RE Induction of cytosolic phospholipase A2 activity by phosphatidic acid and diglycerides in permeabilized human neutrophils: interrelationship between phospholipases D and A2. 1997 Biochem. J. pmid:9065750
Joly F et al. Biosynthesis of paf-acether. Activators of protein kinase C stimulate cultured mast cell acetyltransferase without stimulating paf-acether synthesis. 1990 Biochem. J. pmid:2146953
Fouda SI et al. Effect of lipopolysaccharide on mitogen-activated protein kinases and cytosolic phospholipase A2. 1995 Biochem. J. pmid:8948437
Tao W et al. Arachidonic acid release in rabbit neutrophils. 1989 Biochem. J. pmid:2494986
Vallance SJ et al. Granulocyte-macrophage colony-stimulating factor can stimulate macrophage proliferation via persistent activation of Na+/H+ antiport. Evidence for two distinct roles for Na+/H+ antiport activation. 1990 Biochem. J. pmid:2154185
Hill CE et al. Location of platelet activating factor binding in rat liver. 1988 Biochem. J. pmid:3178735
Kimura K et al. Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver. Involvement of mannose receptors, peptide-leukotrienes and prostaglandins. 1992 Biochem. J. pmid:1317164
Chau LY et al. Agonist-induced down-regulation of platelet-activating factor receptor gene expression in U937 cells. 1994 Biochem. J. pmid:7519853
Dunlop ME and Larkins RG Insulin-dependent contractility of glomerular mesangial cells in response to angiotensin II, platelet-activating factor and endothelin is attenuated by prostaglandin E2. 1990 Biochem. J. pmid:2268285
Montero M et al. Agonist-induced Ca2+ influx in human neutrophils is secondary to the emptying of intracellular calcium stores. 1991 Biochem. J. pmid:1906712
Liu B et al. Prolonged activation of phospholipase D in Chinese hamster ovary cells expressing platelet-activating-factor receptor lacking cytoplasmic C-terminal tail. 1997 Biochem. J. pmid:9355758
Herbert JM Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells. 1992 Biochem. J. pmid:1318021
Raggers RJ et al. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. 2001 Biochem. J. pmid:11463358
Garcia MC et al. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid. 1990 Biochem. J. pmid:1693077
Huang SJ et al. Platelet-activating factor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate stimulates the production of reactive oxygen intermediates in macrophages. 1988 Biochem. J. pmid:2833227
Hallam TJ et al. Relationship between cytoplasmic free calcium and myosin light chain phosphorylation in intact platelets. 1985 Biochem. J. pmid:4091795
Kang JX et al. Characterization of platelet-activating factor binding to human airway epithelial cells: modulation by fatty acids and ion-channel blockers. 1994 Biochem. J. pmid:7526847
van Willigen G and Akkerman JW Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets. 1991 Biochem. J. pmid:1846526
Murphy JF et al. The vitronectin receptor (alpha v beta 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cells. 1994 Biochem. J. pmid:7528011
Chao W and Olson MS Platelet-activating factor: receptors and signal transduction. 1993 Biochem. J. pmid:8391253
Murphy CT and Westwick J Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses. 1992 Biochem. J. pmid:1567363
van Willigen G et al. Exposure of ligand-binding sites on platelet integrin alpha IIB/beta 3 by phosphorylation of the beta 3 subunit. 1996 Biochem. J. pmid:8615768
Asmis R et al. Intracellular Ca2+, inositol 1,4,5-trisphosphate and additional signalling in the stimulation by platelet-activating factor of prostaglandin E2 formation in P388D1 macrophage-like cells. 1994 Biochem. J. pmid:8141766
Sebaldt RJ et al. Quantification of contributions of phospholipid precursors to diradylglycerols in stimulated mononuclear phagocytes. 1992 Biochem. J. pmid:1599420
Churchill L et al. Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells. 1991 Biochem. J. pmid:2064601
Tripathi YB et al. Involvement of tyrosine kinase and protein kinase C in platelet-activating-factor-induced c-fos gene expression in A-431 cells. 1992 Biochem. J. pmid:1382409
Stephens LR et al. Synthesis of myo-inositol 1,3,4,5,6-pentakisphosphate from inositol phosphates generated by receptor activation. 1988 Biochem. J. pmid:2845930
Krump E et al. Leukotriene synthesis in calcium-depleted human neutrophils: arachidonic acid release correlates with calcium influx. 1995 Biochem. J. pmid:7654211
Altin JG et al. Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway. 1987 Biochem. J. pmid:3117040
Evans RD et al. Effects of platelet-activating factor on lipid metabolism in rats in vivo. Origin of the hypertriglyceridaemia. 1991 Biochem. J. pmid:1747129
Kloprogge E and Akkerman JW Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms. 1986 Biochem. J. pmid:3101672
Rice SQ et al. Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor. 1998 Biochem. J. pmid:9494101
Wu J et al. Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity. 2006 Biochem. J. pmid:16255717
Montero M et al. Chemotactic peptide down-regulation of calcium mobilization induced by platelet-activating factor and by leukotriene B4 in human neutrophils is uncovered by protein phosphatase inhibitors. 1994 Biochem. J. pmid:7980418
Soubeyrand S et al. Phospholipase A2 from bovine seminal plasma is a platelet-activating factor acetylhydrolase. 1998 Biochem. J. pmid:9405273
Coffer PJ et al. Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. 1998 Biochem. J. pmid:9405284
Turner JS et al. Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells. 1994 Biochem. J. pmid:8280096
Murphy CT et al. The relationship between cytosolic Ca2+, sn-1,2-diacylglycerol and inositol 1,4,5-trisphosphate elevation in platelet-activating-factor-stimulated rabbit platelets. Influence of protein kinase C on production of signal molecules. 1991 Biochem. J. pmid:1883334
Antonopoulou S et al. Identification of a new endogenous platelet-activating factor-like molecule in gingival crevicular fluid. 1998 Biochem. J. pmid:9480892
Takano H et al. Platelet aggregation induced by platelet-activating factor is suppressed by cystine protease inhibitor. 1991 Biochem. Med. Metab. Biol. pmid:2015107
Akiba S et al. Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. 1998 Biochem. Mol. Biol. Int. pmid:9891858
Tanfani F et al. A sensitive detection of neutrophil activation by fluorescence quenching of membrane inserted singlet oxygen probe. 1994 Biochem. Mol. Biol. Int. pmid:8061626
Calcerrada MC et al. Glutamate release is involved in PAF-increased cyclic GMP levels in hippocampus. 1999 Biochem. Mol. Biol. Int. pmid:10204090
Suzuki H et al. Evidence for the production of platelet-activating factor by murine embryos and its putative role in the maternal physiology. 1995 Biochem. Mol. Biol. Int. pmid:8589634
Shah BH et al. The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx. 1998 Biochem. Pharmacol. pmid:9776305
Yamaguchi M et al. A platelet-activating factor (PAF) receptor deficiency exacerbates diet-induced obesity but PAF/PAF receptor signaling does not contribute to the development of obesity-induced chronic inflammation. 2015 Biochem. Pharmacol. pmid:25577975
Winkler JD et al. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils. 1992 Biochem. Pharmacol. pmid:1449523
Yamazaki Y et al. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice. 2013 Biochem. Pharmacol. pmid:23817078
Le Blanc K et al. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism. 1995 Biochem. Pharmacol. pmid:7786298
Ukena D et al. PAF-receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086. 1989 Biochem. Pharmacol. pmid:2543419
Workman P et al. Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells. 1991 Biochem. Pharmacol. pmid:1989642
Keraly CL et al. The role of extracellular Ca2+ and Na+ in paf-acether-induced human platelet activation. 1989 Biochem. Pharmacol. pmid:2818633
Lamant V et al. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. 1987 Biochem. Pharmacol. pmid:2820421
Beusenberg FD et al. Cyclic-AMP level and eicosanoid release from alveolar macrophages are differentially affected by high and low dose of platelet activating factor. 1994 Biochem. Pharmacol. pmid:8117329
Persico P et al. In vivo and in vitro inhibition of platelet aggregation by SV-IV, a major protein secreted from the rat seminal vesicle epithelium. 1990 Biochem. Pharmacol. pmid:2390113
Appleyard CB and Hillier K Catabolism of platelet-activating factor by human colonic mucosa. Calcium dependence of the catabolizing enzymes. 1992 Biochem. Pharmacol. pmid:1632809
Heller R et al. Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells. 1992 Biochem. Pharmacol. pmid:1322663
Pretolani M and Vargaftig BB From lung hypersensitivity to bronchial hyperreactivity. What can we learn from studies on animal models? 1993 Biochem. Pharmacol. pmid:8452553
Borea PA et al. Temperature dependence of [3H]PAF binding to washed human platelets. 1991 Biochem. Pharmacol. pmid:1847638
Shah BH et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. 1999 Biochem. Pharmacol. pmid:10484074